|
||
© The Rockefeller University Press,
0021-9525/2001//1169 $5.00
The Journal of Cell Biology, Volume 152, Number 6,
, 2001 1169-1182
Original Article |
A Role for Syndecan-1 in Coupling Fascin Spike Formation by Thrombospondin-1
dmcbjca{at}ucl.ac.uk
An important role of cell matrix adhesion receptors is to mediate transmembrane coupling between extracellular matrix attachment, actin reorganization, and cell spreading. Thrombospondin (TSP)-1 is a modulatory component of matrix expressed during development, immune response, or wound repair. Cell adhesion to TSP-1 involves formation of biochemically distinct matrix contacts based on stable fascin spikes. The cell surface adhesion receptors required have not been identified. We report here that antibody clustering of syndecan-1 proteoglycan specifically transduces organization of cortical actin and fascin bundles in several cell types. Transfection of COS-7 cells with syndecan-1 is sufficient to stimulate cell spreading, fascin spike assembly, and extensive protrusive lateral ruffling on TSP-1 or on syndecan-1 antibody. The underlying molecular mechanism depends on glycosaminoglycan (GAG) modification of the syndecan-1 core protein at residues S45 or S47 for cell membrane spreading and on the VC2 region of the cytoplasmic domain for spreading and fascin spike formation. Expression of the VC2 deletion mutant or GAG-negative syndecan-1 showed that syndecan-1 is necessary in spreading and fascin spike formation by C2C12 cells on TSP-1. These results establish a novel role for syndecan-1 protein in coupling a physiological matrix ligand to formation of a specific matrix contact structure.
Key Words: cell adhesion extracellular matrix proteoglycan actin protrusions
© 2001 The Rockefeller University Press
| Introduction |
|---|
|
|
|---|
This laboratory has shown that cell attachment and spreading on TSP-1 substrata is associated with organization of the cortical actin cytoskeleton to form stable, radial spikes which contain F-actin and the actin-binding protein fascin (Adams 1995, Adams 1997b). These spike structures and associated lamellae mediate adhesion to TSP-1 and are also needed in cell motile behavior on TSP-1 (Adams 1997b). Fascin spikes are assembled in the absence of focal contacts, and their assembly is dependent on the maintenance of a pool of the nonphosphorylated, actin-binding form of fascin and the regulated activities of Rac and Cdc42 small GTPases (Adams 1995; Adams et al. 1999; Adams and Schwartz 2000). Thus, the interactions of TSP-1 at the plasma membrane transduce signals into cells which have highly specific effects on the organization of F-actin and fascin within the cell cortex. To understand the molecular basis for this response, it is of obvious relevance to identify the necessary adhesive receptors.
Each subunit of the TSP-1 homotrimer contains four major domains that are involved in cell attachment to TSP-1: the NH2-terminal domain, the type 1 repeats, an arginine-glycine-aspartate motif in the last type 3 repeat, and the COOH-terminal globular domain (for review see Adams 1997a). Widespread analyses of many cell types have established that each domain interacts with different cell surface–binding partners. The NH2-terminal domain has a high affinity for heparin and heparan sulfate (HS)-glycosaminoglycans (GAGs) and can mediate endocytosis of TSP-1 in conjunction with low density lipoprotein receptor–related protein (Sun et al. 1989; Godyna et al. 1995; Mikhailenko et al. 1995). The type 1 repeats contain multiple binding sites for GAGs and a cell type–restricted receptor, CD36 (Asch et al. 1992; Guo et al. 1992a,Guo et al. 1992b; Pancake et al. 1992; Li et al. 1993; Gantt et al. 1997). The arginine-glycine-aspartate site, which is active in a conformation-dependent manner according to the nature of the disulfide pairings within the type 3 repeats, binds
vβ3 integrin on endothelial and smooth muscle cells and to some extent
IIbβ3 on platelets (Lawler et al. 1988; Lawler and Hynes 1989; Sun et al. 1992). Cell attachment involving other integrins has been reported in individual cell types, for example, a role for
4β1 and
5β1 integrins in attachment of activated T cells, but the binding sites for these interactions have not been mapped precisely (Yabkowitz et al. 1993). Activated
3β1 integrin binds a site within the NH2-terminal domain (Krutzsch et al. 1999). Two peptide motifs in the COOH-terminal globular domain act as binding sites for CD47/IAP (Gao et al. 1996).
The multiplicity of cell-binding sites presented by the intact TSP-1 molecule complicates analysis and interpretation of the activities of individual adhesive receptors in transmembrane coupling and organization of the actin cytoskeleton. Yet a knowledge of the mechanism involved is critical in understanding how TSP coordinates the assembly of fascin spikes in preference to other types of matrix contacts. Fascin spikes are also formed by cells adherent to Engelbreth-Holm-Swarm laminin and tenascin C and are localized at the leading edge of migratory cells where they have been functionally implicated in motile behavior (Adams 1997b; Fischer et al. 1997; Yamashiro-Matsumura et al. 1998). Thus, identification of the coupling mechanism for TSP-1 could prove of general significance in understanding how matrix contacts are coordinated by cells within complex, physiological extracellular matrices.
We hypothesized that ligation and clustering of individual adhesive receptors by specific antibodies could be used to identify roles for TSP-1–binding receptors in fascin spike assembly. We report here that, either by antibody clustering of syndecan-1 or by transfection of syndecan-1 expression constructs, ligation of syndecan-1 specifically coordinates the organization of fascin structures in several cell types. The molecular mechanism of these effects depends on the presence of GAG chains and on the cytoplasmic domain of the core protein. These novel results establish syndecan-1 as a functionally important transducer of fascin spike formation by TSP-1.
| Materials and Methods |
|---|
|
|
|---|
5 integrin subunit (CD49e; antibody 5H10-27), and mouse β3 integrin subunit (CD61; hamster antibody 2C9.G2) were obtained from BD PharMingen. N-18 goat antibody to the NH2 terminus of mouse syndecan-1 was obtained from Santa Cruz Biotechnology, Inc. Rabbit antibody to CD36, reactive with human and mouse CD36, was from Research Diagnostics. Mouse monoclonal antibody miap 301 to mouse CD47/IAP and mouse hindlimb muscle from neonatal wild-type or CD47-null mice were gifts from Frederick Lindberg (University of Washington, St. Louis, MO) (Lindberg et al. 1996). Primary skeletal myoblasts were prepared from the dissected tissue by sequential trypsinization and replating, and their CD47 status was confirmed by immunostaining. Mouse monoclonal antibodies to human adhesion receptors included antibody SMO to CD36 (Serotec) (Hogg et al. 1984), BRIC 126, B6H12, and 2E11 to CD47 (Biodesign; AMS Biotechnology) (Avent et al. 1988; Brown et al. 1990), monoclonal antibody 13 to β1 integrin (Akiyama et al. 1989), LM609 to
vβ3 integrin (Cheresh 1987), and antibodies 1D4 and BB4 to syndecan-1 (Biodesign) (Dore et al. 1998). Purified nonimmune rat or mouse immunoglobulins were obtained from Sigma-Aldrich.
FACS® Analysis
Single cell suspensions of 106 C2C12 or COS-7 cells were incubated with antibodies to adhesion receptors diluted in PBS on ice for 30 min. Cells were washed three times in PBS at 4°C, resuspended in 1:50 dilutions of the appropriate FITC-conjugated secondary antibody, and incubated for 30 min on ice. The cells were washed again and passed through a Becton Dickinson FACScanTM. 10,000 cells were analyzed per sample.
Extraction of Proteoglycans
Cells were plated at 107 cells per 90-mm dish and allowed to attach for 2 h. Cells were then lysed in 8 M urea, 0.2% Triton X-100, 10 mM Tris-HCl, pH 8.0, and sonicated on ice, using a Branson model 450 Sonifier in four 10-s bursts at amplitude setting 8 with 10 s cooling time allowed between each burst. The lysates were clarified by centrifugation, and lysate corresponding to 107 cells was combined with 100-µl packed volume of DEAE-Sephacel (Sigma-Aldrich) which had been prepared by washing in 8 M urea, 0.2% Triton X-100, 10 mM Tris-HCl, pH 8.0. The mixture was rotated end-over-end for 16 h at 4°C. The DEAE-Sephacel beads were washed in TBS and eluted with 1 M NaCl in lyase digestion buffer (100 mM Hepes, pH 6.5, 10 mM CaCl2, 0.5% CHAPS, 0.2 mg/ml BSA). Proteoglycans were collected as described by Sanderson et al. 1992. Enzymatic cleavage of chondroitin sulfate (CS)- and HS-GAG chains was performed by diluting the proteoglycan samples two times with dH2O followed by incubation with either 50 mU/ml chondroitinase ABC, 50 mU/ml heparitinase II (Seikagaku), or a mixture of both enzymes for 2 h at 37°C. A second addition of enzyme(s) was made and the reaction mixtures were incubated for a further 2 h at 37°C. Samples were then concentrated and desalted by centrifugation in Centricon 10 concentrators (Amicon) and combined with SDS-PAGE sample buffer containing 100 mM DTT as a reducing agent. Electrophoresis of samples was performed under reducing conditions as described by Koda et al. 1985, using 4–15% SDS-polyacrylamide gradient gels and Tris/borate buffer containing 40 mM Tris, 60 mM boric acid, 0.8 mM EDTA, 1 mM Na2SO4, and 0.1% SDS. Samples were electroblotted overnight at 60 V onto nitrocellulose (0.22-µm pore size; Bio-Rad Laboratories) and probed for syndecan-1 by incubation with 5 µg/ml monoclonal antibody 281.2 for 1 h, followed by ECL detection of alkaline phosphatase–conjugated secondary antibody (Tropix; PerkinElmer) using Hyperfilm ECL (Amersham Pharmacia Biotech).
Transfection and Cytoskeletal Organization Assays
Cells for transient transfection were plated at 30–40% confluency and transfected with plasmid DNA by use of Superfect reagent (QIAGEN) according to the manufacturer's instructions. The plasmids used included expression plasmids for enhanced green fluorescent protein (EGFP) (CLONTECH Laboratories, Inc.), EGFP-fascin, wild-type and GAG-addition site mutants of mouse syndecan-1 (Saunders et al. 1989; Langford et al. 1998), and wild-type rat syndecan-2 (Klass et al. 2000). Syndecan-1 mutants lacking the VC2 regions of the cytoplasmic domain were prepared by PCR-based mutagenesis using as a primer pair the forward primer 5'-TCTGGGCAGCATGAGACG and the reverse primer 5'-CTGGTAGGCACCGCCATTGGCT and Pfu polymerase (New England Biolabs, Inc.). The PCR product was cloned into the pCDNA3 expression vector by TOPO cloning kit (Invitrogen). The 5' and 3' junctions of the cDNA were confirmed by DNA sequencing, using the dideoxy chain-termination method and standard forward and reverse vector primers. Expression of cDNAs was confirmed by in vitro translation using the TNT kit (Promega).
Transiently transfected cells were used in adhesion assays 36–42 h after transfection. Glass coverslips were coated with 50 nM recombinant human TSP-1, prepared using the baculovirus system as described (Adams et al. 1998) or with the appropriate immunoglobulins overnight at 4°C. To orient antireceptor antibodies, dishes were first coated with 10 µg/ml avidin (Vector Laboratories) and then with 10 µg/ml biotin-conjugated antiimmunoglobulin antibodies of the appropriate species specificity (Vector Laboratories or ICN Biomedicals). Surfaces were then coated at 4°C overnight with 40 µg/ml solutions of the antireceptor antibodies. All coverslips were rinsed in TBS and blocked with 2 mg/ml heat-denatured BSA for 1 h. Single cell suspensions, prepared by release with 10 mM EDTA or by trypsinization, were allowed to attach for 1 h at 37°C in serum-free DME. Nonattached cells were removed by rinsing in TBS and the adherent cells were fixed before analysis of cytoskeletal organization by indirect immunofluorescence. For staining with rhodamine-phalloidin, antivinculin monoclonal VIN 11.5 (Sigma-Aldrich), or mouse monoclonal 4G10 to phosphotyrosine (Upstate Biotechnology) cells were fixed in 3.7% paraformaldehyde and processed as described previously (Adams 1995). For staining with monoclonal antibody to fascin (Dako), cells were fixed in absolute methanol and fascin localization was detected with an FITC-conjugated goat anti–mouse secondary antibody (ICN Biomedicals). For quantitation of spread area or length of fascin actin bundles either digital images were processed in ImagePro Plus or tracings from photographic enlargements were scanned into Adobe Photoshop® and then processed. Excel worksheets were used to calculate descriptive statistics and to determine significance using an unpaired two-tailed t test.
Cell Motility Measurements
Nunc slideflasks were coated with antibodies to adhesion receptors as described above or with 50 nM recombinant TSP-1 and blocked with heat-denatured BSA. EDTA-released cells were suspended at 3 x 105 cells/ml and plated for 30 min. Nonadherent cells were removed and the behavior of the attached cells was tracked over the next 1.5 h by time-lapse videomicroscopy as described (Adams 1997b). Cells were recorded at 10 frames/min and alterations in spread area, ruffling behavior, or cell locomotion were measured from traces. Ruffling behavior was scored as the extension of lateral, substratum-adherent ruffles at cell margins (lateral ruffles). Cell locomotion was scored as the displacement of the cell centroid over time. The extension of short, dynamic projections from the dorsal cell surface (apical projections) was also scored. At least 50 cells were traced for each transfection condition, and five replicate experiments were analyzed in total. For parameters that appeared altered between control or experimental transfections, statistical significance was determined in Microsoft Excel using a two-tailed t test.
| Results |
|---|
|
|
|---|
2β1,
3β1,
4β1,
5β1,
7β1, and
vβ1 but not
1β1 integrins. The cells also express the
vβ3 and
vβ5 heterodimers (Adams et al. 1998 and references therein; Adams, J.C., unpublished data). The expression profiles for CD47 and the integrin subunits were very similar in trypsinized or EDTA-treated cells (shown for β1 staining only; Fig. 1 A). However, after trypsin treatment for 2 min at 37°C expression of syndecan-1 was reduced and more heterogeneous (Fig. 1 A, panel Syn-1[T]). As expected, because of the known protease sensitivity of the syndecan-1 extracellular domain, trypsinization for 5 min at 37°C resulted in a complete loss of cell surface syndecan-1 (data not shown; Fitzgerald et al. 2000).
|
120 and 97 kD with associated smearing (Fig. 1 B, lane 1). Upon digestion with chondroitinase ABC, the 120-kD band was much reduced, and the majority of syndecan-1 appeared as a broad band in the range of 66–97 kD that comigrated with core protein (Fig. 1 B, lanes 2 and 4). The breadth of this band likely relates to the tendency of syndecan-1 cores to form SDS-resistant oligomers as well as the presence of various HS substitutions. Upon digestion with heparitinase II, the 120-kD band was lost, and syndecan-1 appeared as an extended higher molecular weight smear as well as the
97-kD species (Fig. 1 B, lane 3). Double digestion with both enzymes resulted in complete conversion of the diffuse higher molecule weight forms into the core protein band (Fig. 1 B, lane 4). Thus, in C2C12 cells, syndecan-1 is expressed as a mixed CS/HS proteoglycan.
Direct Ligation of Individual TSP-1 Adhesion Receptors Has Distinct Effects on F-Actin Organization
To dissect the effects of ligation and clustering of individual TSP-1 receptors on cell attachment and actin cytoskeletal organization, the panel of antibodies reactive with the extracellular domains of mouse β1 or β3 integrin subunits, CD47, or syndecan-1 were used as adhesive substrata for C2C12 cells. All the antibodies supported quantitatively increased cell attachment relative to nonimmune rat IgG. C2C12 underwent partial spreading on the β1 integrin subunit antibody and displayed organization of F-actin at cell margins (Fig. 2 and Table ). Cells on the β3 integrin subunit antibody also spread partially and developed concentrations of F-actin at points on the cell surface (Fig. 2). On the CD47 antibody, cells spread more extensively and displayed larger actin-containing ruffles at cell margins (Fig. 2). For all these antibodies, similar results were obtained using either trypsinized or EDTA-disaggregated cells (shown in Fig. 2 for trypsinized cells only).
|
|
50 µg/ ml of the antibody (data not shown).
|
68% of the cells showed fascin spikes or less well-organized fascin-containing projections (Fig. 3). Quantification of these results confirmed that the syndecan-1 antibody strongly and specifically evoked the formation of fascin spikes (Table ). Because antibodies to different epitopes on CD47 vary in their ability to perturb CD47-mediated functions (Brown et al. 1990), we further examined the role of CD47 in fascin spike formation by comparing the ability of wild-type and CD47-null primary skeletal myoblasts to form fascin spikes on TSP-1. The two cell populations were indistinguishable with regard to adhesion and the organization of fascin spikes (Fig. 3 B). We extended the analysis of receptor ligation by antibodies to additional cell types which show different degrees of spreading on TSP-1 substrata. MEF-1 mouse fibroblasts spread and form fascin spikes and filopodia on TSP-1 (Fig. 4 A). Cells remained rounded with diffuse fascin when plated on the anti–mouse β1, β3, or CD47 antibodies (shown for β1 only, Fig. 4 A). When plated on the 281-2 antibody to mouse syndecan-1, MEF-1 formed broad circumferential lamellae containing radial F-actin ribs which corresponded to sites where fascin and actin were bundled (Fig. 4 A). HLMECs express fascin and syndecan-1 but as reported for endothelial cells from other blood vessel sources, do not spread on TSP-1 (Fig. 4 B; Lawler et al. 1988; Murphy-Ullrich and Hook 1989; Mertens et al. 1992; Adams, J.C., unpublished data). The cells show specific enrichment of F-actin and fascin structures at cell margins when attached to TSP-1 (Fig. 4 B). HLMECs attached to surfaces coated with antibodies to human β1, β3, CD47, or syndecan-1 and showed most microfilament organization on the β1 antibody. However, fascin was completely diffuse in these cells and was not enriched at cell margins (Fig. 4 B; data not shown). On either of two antibodies to human syndecan-1, HLMECs formed short marginal structures which contained F-actin and fascin (shown for BB4 antibody only, Fig. 4 B). We also examined fascin localization in HLMECs plated on surfaces coated with SMO antibody to human CD36 (Hogg et al. 1984). The cells remained rounded and smooth edged and did not show specific localization of fascin (data not shown). Neither the BRIC 126, B6H12, nor 2E11 antibodies to human CD47 caused fascin–actin bundling (Fig. 4 B; data not shown). Thus, in several cell types from different tissue sources, ligation of syndecan-1 specifically promoted the organization of cortical fascin independently of the degree of cell spreading.
|
Syndecan-1 Is Sufficient for Fascin Spike Formation
To establish whether syndecan-1 is sufficient to mediate assembly of fascin and actin-containing spikes, we examined the effects of transient expression of mouse syndecan-1 in a heterologous cell system, green monkey COS-7 cells. COS-7 cells contain appropriate endogenous coupling mechanisms for spike formation because they express fascin and undergo limited spike formation when attached to TSP-1 (Adams 1997b). FACS® analysis established that the 281-2 antibody to mouse syndecan-1 did not stain the surface of live COS-7 cells. COS-7 cells did not attach over background to surfaces coated with syndecan-1 antibody (data not shown). COS-7 cells transiently cotransfected with control, empty expression plasmid, and EFGP-fascin or expression plasmid encoding syndecan-1 plus EGFP-fascin were disaggregated by EDTA treatment and used in adhesion assays on TSP-1. Indirect immunofluorescent staining of live cells was used to confirm the cell surface expression of syndecan-1 by transfected cells (data not shown).
The vector-transfected cells attached to TSP-1 remained rounded, and showed concentrations of actin and fascin at cell margins indistinguishable from those of untransfected cells (Fig. 5). In marked contrast, syndecan-1 transfectants showed greatly enhanced spreading on TSP-1. The cells spread to form adherent lamellipodial sheets with marginal F-actin and fascin-containing projections of varying lengths (Fig. 5). The syndecan-1 transfectants attached on the syndecan-1 antibody also showed greatly increased spreading which involved the formation of flatly spread lamellae in which radial projections containing F-actin and fascin were present at spread margins or extended as individual projections beyond the edge of the lamellae (Fig. 5). This effect involved a dramatic increase in the number of fascin spikes per cell (see Fig. 7 A). Cell membrane spreading involved a threefold increase in cell area (statistically significant at P = 0.0001; see Fig. 7 A). To examine the specificity of this effect, the syndecan-1 transfectants were plated on another matrix ligand, fibronectin. No increase in cell area or alteration in major F-actin structures was observed (Fig. 5; data not shown). Thus, the effects of syndecan-1 depend on its ligation by specific ligands and are not simply a consequence of the surface expression of syndecan-1.
|
|
|
To establish whether the cytoplasmic domain of the syndecan-1 core protein was critical for the formation of fascin spikes, COS-7 cells were transfected with a cytoplasmic deletion mutant of syndecan-1. All syndecans have short, 34-residue cytoplasmic domains that contain highly conserved membrane-proximal and COOH-terminal sequences, the C1 and C2 regions, respectively, separated by variable (V) regions which are unique to each family member. The C1 region is important for membrane translocation of syndecan-1 (Miettinen et al. 1994). Expression of syndecan-1 in which the V and C2 regions of the cytoplasmic domain had been deleted, syn-1/
VC2, did not promote either fascin spikes or lamellar cell spreading on TSP-1 (Fig. 6). Expression of the equivalent deletion mutant lacking the three GAG substitution sites, syn-1/TGM/
VC2, had similar effects (Fig. 6).
We also compared the effects of syndecan-2, a syndecan family member that is expressed by many mesenchymal cells, on cytoskeletal organization by cells adherent to TSP-1. The extracellular domain of syndecan-2 contains three analogous GAG addition sites, but the polypeptide sequence of the extracellular domain and of the cytoplasmic V region are unrelated to that of syndecan-1 (for review see Bernfield et al. 1999). Expression of syndecan-2 in COS-7 cells stimulated cell spreading on TSP-1 by 50% (significant at P = 0.04). However, the spread cells were completely smooth edged and lacked fascin spikes or cortical lamellipodia (Fig. 6 and Fig. 7A and Fig. B). Cumulatively, these results demonstrate that the syndecan-1 cytoplasmic domain in combination with effects from GAG chains are jointly needed in coupling extracellular TSP-1 to membrane spreading and fascin cytoskeletal organization.
To determine whether these effects were specific to TSP-1 ligation of syndecan-1, we examined the responses of the transfectants to plating on syndecan antibody or on fibronectin. On the syndecan-1 antibody, the syn-1/TGM transfectants spread and organized fascin–actin bundles, whereas the syn-1/
VC2 transfectants remained round as they did on TSP-1 (Fig. 8 A). Thus, even upon direct, monospecific ligation of the core protein the V and C2 cytoplasmic regions are needed to transduce cytoskeletal organization. To further confirm that the effects of syndecan-1 expression cells resulted from specific ligation of syndecan-1 and not as an immediate consequence of syndecan overexpression, we examined cell behavior on fibronectin. No alterations in cell spreading or fascin distribution were apparent in cells transfected with syn-1/TGM, syn-1/
VC2, or syndecan-2 (Fig. 8 A). These cDNAs used were all translatable with equivalent efficiencies (Fig. 8 B), and both Syn1/TGM and Syn1/
VC2 proteins were expressed at comparable levels to the wild-type syndecan-1 as determined by FACS® analysis or immunoblot (Fig. 8 B; data not shown). Thus, the differing effects of the various syndecan-1 proteins on fascin organization most likely result from ligation of syndecan-1 by appropriate specific ligands.
|
VC2 or syn-1/TGM constructs were transiently transfected into C2C12 cells. The syn-1/
VC2 molecule acted as an effective dominant negative, in that, transfected cells which attached to TSP-1 did not spread or form fascin spikes (Fig. 9 C). Cells expressing the syn-1/TGM construct were altered in morphology on TSP-1, yet formed fascin projections (Fig. 9 D). Thus, in C2C12 cells as in COS-7 cells, GAG substitution of syndecan-1 is important for cell spreading on TSP-1 but does not appear to be required in fascin spike organization.
|
VC2 construct did not show lateral ruffles and thus appeared similar to vector transfectants (data not shown). To examine the specificity of the ruffling response, we compared the motility of cells transfected with syndecan-2. These cells showed no lateral ruffling. Lateral ruffling thus specifically correlated with the formation of fascin spikes (Fig. 7 B and Fig. 10). The alterations in lateral ruffling occurred in the absence of any change in extension of apical projections, and thus related specifically to adhesion-dependent motility and not to a general change in membrane dynamics (Fig. 10). Interestingly, despite the large increases in cell spreading and lateral ruffling activity, syndecan-1 transfectants did not translocate over the substratum. For adhesion to TSP-1, this result was obtained using coating concentrations of 25 or 50 nM. For adhesion to the syndecan-1 antibody, this result was confirmed at a range of antibody-coating concentrations from 5 to 50 µg/ml. For all concentrations that supported cell spreading, no stimulation of cell locomotion was observed (data not shown). Thus, under these experimental conditions, the most dramatic effect of syndecan-1 ligation on motile behavior is the stimulation of active ruffling protrusions at lateral cell margins (Fig. 10).
|
| Discussion |
|---|
|
|
|---|
Syndecan-1 and thrombospondin-1 are coexpressed in many tissues, including skeletal muscle, during development (Corless et al. 1992). TSP-1 is known as a heparin-binding protein, and each subunit of the trimer contains multiple GAG-binding motifs within the NH2-terminal domain and type 1 repeats (for review see Adams 1997a). Dependent on the tissue source and structural characteristics of the GAGs, TSP-1 binds both HS- and CS-GAGs (Pancake et al. 1992; Herndon et al. 1999). GAG-dependent cell attachment or adhesion to TSP-1 has been reported in many cell types (for example, Roberts et al. 1987; Kaesberg et al. 1989; Adams and Lawler 1993; Gantt et al. 1997; Wilson et al. 1999). Disruption of focal contacts by soluble TSP-1 and the endocytosis of TSP-1 by low density lipoprotein receptor–related protein are also heparin-inhibitable processes (Murphy-Ullrich and Hook 1989; Godyna et al. 1995; Mikhailenko et al. 1995; Chen et al. 1996). However, the core proteins involved in GAG-mediated adhesion have remained unknown. By affinity chromatography, syndecan-1 was identified as the major thrombospondin-binding HS proteoglycan in mammary epithelial cell extracts (Sun et al. 1989). Our data now provide evidence for a role of syndecan-1 in cell spreading and major cytoskeletal responses to TSP-1.
Fascin spikes identify a specific matrix contact structure formed during cell spreading on TSP-1 which has functional roles in cell adhesion and motility on matrix substrata (Adams 1995, Adams 1997b). Interestingly, fascin spikes are also formed upon cell adhesion to tenascin-C and laminin-1, both of which are also ligands for syndecan-1 (Adams 1997b; Fischer et al. 1997; for review see Bernfield et al. 1999). Although syndecan-1 has a peripheral distribution in freshly spreading cells, it is not present in focal contacts and colocalizes with actin microfilaments when clustered and in long-term adherent cells (Rapraeger et al. 1986; Carey et al. 1994a). Antibody-mediated clustering of syndecan-1 also promotes actin reorganization in preadherent Schwann cells and Raji cells (Carey et al. 1994b; Lebakken and Rapraeger 1996). Our results link the binding of syndecan-1 by a physiological extracellular matrix ligand, TSP-1, to a specific effect on the actin cytoskeleton, that is, the formation of fascin spikes and ribs in adherent lamellipodia. Furthermore, this effect of syndecan-1 ligation compared with the effects of ligation of CD36, CD47, β1, or β3 integrins adhesive receptors implies a central role for syndecan-1 in extracellular coordination of actin bundling by fascin.
Several cell types show quantitatively high attachment to TSP-1 but do not undergo spreading (for example, Asch et al. 1991; Adams and Lawler 1993). This property does not show a simple correlation with recognition of a particular adhesive domain of TSP-1 (Adams and Lawler 1993) nor does it correlate in all cell types with a lack of fascin expression (Adams 1997a,Adams 1997b). We examined HLMECs as a example of a fascin-positive cell type that does not spread on TSP-1 yet is functionally responsive to TSP-1 (Good et al. 1990). Interestingly, these cells did not spread on antisyndecan antibodies, although cortical enrichments of actin and fascin were apparent on both TSP-1– or antibody-coated surfaces. Several possible mechanisms could underlie this effect. A certain level of syndecan-1 expression could be necessary to promote cell spreading and cytoskeletal organization on TSP-1. However, although the microvascular endothelial cells express lower levels of syndecan-1 than do epidermal keratinocytes, as determined by FACS® analysis, epidermal keratinocytes also do not spread on TSP-1 (Adams and Lawler 1993; Adams, J.C., unpublished data). In C2C12 cells, overexpression of either dominant negative or constitutively active forms of Cdc42 or Rac small GTPases correlates with cell rounding on TSP-1 (Adams and Schwartz 2000). An interesting speculation is that the constitutive lack of spreading of certain cell types on TSP-1 could result from differences in the sizes of the active pools of these signaling mediators.
Syndecans have principally been characterized as coreceptors with FGF receptors or integrin-adhesive receptors (for reviews see Bernfield et al. 1999; Woods and Couchman 2000). In particular, syndecan-4 binds the major heparin-binding site of fibronectin and acts coordinately with integrins such as
5β1 in the assembly of focal adhesions (Woods et al. 1993; Couchman and Woods 1999; Longley et al. 1999; Saoncella et al. 1999). Ligation of
5β1 integrin leads to activation of protein kinase C. By binding and activating protein kinase C, syndecan-4 appears to potentiate this signal for focal adhesion assembly (Vuori and Ruoslahti 1993; Oh et al. 1997a,Oh et al. 1997b). Fibronectin supports only limited and transient formation of fascin spikes and ruffles during the initial stages of cell spreading because
5β1-dependent activation of protein kinase C promotes phosphorylation of fascin and thereby downregulates its actin-binding activity (Adams 1995; Adams et al. 1999). Thus, the molecular process we have defined for syndecan-1 as a transducer of fascin spike formation appears distinct from the mechanisms by which syndecan-4 participates in focal contact assembly.
In examining the mechanism by which syndecan-1 mediates this effect on fascin, we have uncovered a dualistic activity of syndecan-1. Whereas the effect of direct antibody ligation of the syndecan-1 extracellular domain or transfection of wild-type syndecan-1 stimulated both lamellipodial cell spreading and associated formation of fascin- and actin-containing spikes and ribs, GAG modifications at specific sites on the extracellular domain were needed to support lamellipodial spreading on TSP-1. Cells expressing GAG-negative syndecan-1 or loss-of-function mutants at the S45 or S47 attachment sites showed florid formation of fascin spikes on TSP-1 and poor membrane spreading. This effect was separable from a necessity for the VC2 portion of the cytoplasmic domain in both fascin spike formation and cell spreading.
As a model to explain these results, we propose two separate activities of the extracellular domain: (a) an interaction of TSP-1 with the core protein that is transduced through the cytoplasmic domain, which principally couples spike formation and is permissive for cell spreading; and (b) a GAG-mediated receptor-clustering effect which acts to promotes cell membrane spreading. Although a protein–protein interaction of syndecan-1 with TSP-1 has not been reported, a separate role for the core protein would not be entirely unprecedented within the syndecan family. A region in the extracellular domain of syndecans is involved in lateral homophilic association (for reviews see Rapraeger and Ott 1998; Zimmermann and David 1999). The extracellular domain of syndecan-4 presented as a recombinant, monomeric, unglycosylated protein specifically supports fibroblast attachment and binds cell surfaces with nanomolar affinity (McFall and Rapraeger 1997, McFall and Rapraeger 1998). There are several reports of effects of syndecan-1 on cell morphology which do not require the cytoplasmic domain, and thus a separable role of the GAG chains appears plausible (Lebakken and Rapraeger 1996; Liu et al. 1998). Effects on F-actin distribution that depend on the cytoplasmic domain have also been reported (Carey et al. 1996).
Members of the PDZ family of proteins are known binding partners for the C2 COOH-terminal region of syndecans (Grootjans et al. 1997; for reviews see Rapraeger and Ott 1998; Bernfield et al. 1999; Zimmermann and David 1999). However, transfection of syndecan-2, which has similarly positioned GAG attachment sites and shares the common C1 and C2 cytoplasmic regions with syndecan-1, promoted cell spreading but did not lead to organization of fascin spikes on TSP-1. The V region of syndecan-4 uniquely binds and activates protein kinase C (Oh et al. 1997a; for reviews see Rapraeger and Ott 1998; Woods and Couchman 1998). The V regions of other syndecans might have other unique binding partners. Our results define a novel and specific requirement for syndecan-1 in coupling between TSP-1 and fascin spike formation. Further studies will be directed towards defining the molecular interactions responsible for the recruitment of fascin and actin into these cortical structures.
| Acknowledgments |
|---|
We thank the Wellcome Trust for their financial support (grant 038284).
Submitted: 9 August 2000
Revised: 10 January 2001
Accepted: 11 January 2001
Abbreviations used in this paper: CS, chondroitin sulfate; EGFP, enhanced green fluorescent protein; GAG, glycosaminoglycan; HLMEC, human lung microvascular endothelial cell; HS, heparan sulfate; TSP, thrombospondin.
| References |
|---|
|
|
|---|
Adams J.C.. Formation of stable microspikes containing actin and the 55 kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1implications for the anti-adhesive activities of thrombospondin-1, J. Cell Sci, 108, 1995, 1977–1990.[Abstract]
Adams J.C.. Thrombospondin-1, Int. J. Biochem. Cell Biol, 29, 1997, 861–865a.[Medline]
Adams J.C.. Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes, Mol. Biol. Cell., 8, 1997, 2345–2363b.
Adams J.C. & Lawler J.. Diverse mechanisms for cell attachment to platelet thrombospondin, J. Cell Sci, 104, 1993, 1061–1071.[Abstract]
Adams J.C. & Lawler J.. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1, Mol. Biol. Cell., 5, 1994, 623–637.
Adams J.C. & Schwartz M.A.. Stimulation of fascin spikes by thrombospondin-1 is mediated by the GTPases Rac and Cdc42, J. Cell Biol, 150, 2000, 807–822.
Adams J.C., Seed B. & Lawler J.. Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1, EMBO (Eur. Mol. Biol. Organ.) J, 17, 1998, 4964–4974.[Medline]
Adams J.C., Clelland J.D., Collett G.D.M., Matsumura F., Yamashiro S. & Zhang L.. Cell-matrix adhesions differentially regulate fascin phosphorylation, Mol. Biol. Cell, 10, 1999, 4177–4190.
Akiyama S.K., Yamada S.S., Chen W.T. & Yamada K.M.. Analysis of fibronectin receptor function with monoclonal antibodiesroles in cell adhesion, migration, matrix assembly, and cytoskeletal organization, J. Cell Biol, 109, 1989, 863–875.
Asch A.S., Templer J. & Silberger S.. Cellular attachment to thrombospondincooperative interactions between receptor systems, J. Biol. Chem, 266, 1991, 1740–1745.
Asch A.S., Silbiger S., Heimer E. & Nachman R.L.. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding, Biochem. Biophys. Res. Commun, 182, 1992, 1208–1217.[Medline]
Avent N., Judson P.A., Parsons S.F., Mallinson G., Anstee D.J., Tanner M.J., Evans P.R., Hodges E., Maciver A.G. & Holmes C.. Monoclonal antibodies that recognize different membrane proteins that are deficient in Rh-null human erythrocytes. One group of antibodies reacts with a variety of cells and tissues whereas the other group is erythroid-specific, Biochem. J, 251, 1988, 499–505.[Medline]
Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J. & Zako M.. Functions of cell surface heparan sulfate proteoglycans, Annu. Rev. Biochem, 68, 1999, 729–777.[Medline]
Bornstein P.. Diversity of function is inherent in matricellular proteinsan appraisal of thrombospondin-1, J. Cell Biol, 130, 1995, 503–506.
Brown E., Hooper L., Ho T. & Gresham H.. Integrin-associated proteina 50 kD plasma-membrane antigen physically and functionally associated with integrins, J. Cell Biol, 111, 1990, 2785–2794.
Carey D.J., Stahl R.C., Cizmeci-Smith G. & Asundi V.K.. Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading, J. Cell Biol, 124, 1994, 161–170a.
Carey D.J., Stahl R.C., Tucker B., Bendt K.M. & Cizmeci-Smith G.. Aggregation-induced association of syndecan-1 with microfilaments mediated by the cytoplasmic domain, Exp. Cell Res, 214, 1994, 12–21b.[Medline]
Carey D.J., Bendt K.M. & Stahl R.C.. The cytoplasmic domain of syndecan-1 is required for cytoskeleton association but not detergent insolubility, J. Biol. Chem, 271, 1996, 15253–15260.
Chen H., Sottile J., Strickland D.K. & Mosher D.F.. Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related proteinlocalization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1, Biochem. J., 318, 1996, 959–963.[Medline]
Cheresh D.A.. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor, Proc. Natl. Acad. Sci. USA, 84, 1987, 6471–6475.
Chiquet-Ehrismann R.. Inhibition of cell adhesion by anti-adhesive molecules, Curr. Opin. Cell Biol, 7, 1995, 715–719.[Medline]
Clark E.A. & Brugge J.S.. Integrins and signal transduction pathwaysthe road taken, Science, 268, 1995, 233–239.
Corless C.L., Mendoza A., Collins T. & Lawler J.. Colocalization of thrombospondin and syndecan during murine development, Dev. Dyn, 193, 1992, 346–358.[Medline]
Couchman J.R. & Woods A.. Syndecan-4 and integrinscombinatorial signaling in cell adhesion, J. Cell Sci, 112, 1999, 3415–3420.[Abstract]
Dore J.M., Morard F., Vita N. & Wijdenes J.. Identification and location on syndecan-1 core protein of the epitopes of B-B2 and B-B4 monoclonal antibodies, FEBS Lett, 426, 1998, 67–70.[Medline]
Fischer D., Tucker R.P., Chiquet-Ehrismann R. & Adams J.C.. Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes, Mol. Biol. Cell, 8, 1997, 2055–2075.
Fitzgerald M.L., Wang Z., Park P.W., Murphy G. & Bernfield M.. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3–sensitive metalloproteinase, J. Cell Biol, 148, 2000, 811–824.
Gantt S.M., Clavijo P., Bai X., Esko J.D. & Sinnis P.. Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG, J. Biol. Chem, 272, 1997, 19205–19213.
Gao A.-G., Lindberg F.P., Dimitry J.M., Brown E.J. & Frazier W.A.. Thrombospondin modulates
vβ3 function through integrin-associated protein, J. Cell Biol, 135, 1996, 533–544.
Good D.J., Polverini P.J., Rastinejad F., LeBeau M.M., Lemons R.S., Frazier W.A. & Bouck N.P.. A tumor-suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin, Proc. Natl. Acad. Sci. USA, 87, 1990, 6624–6628.
Godyna S., Liau G., Popa I., Stefansson S. & Argraves W.S.. Identification of the low density lipoprotein receptor–related protein (LRP) as an endocytic receptor for thrombospondin-1, J. Cell Biol, 129, 1995, 1403–1410.
Grootjans J.J., Zimmermann P., Reekmans G., Smets A., Degeest G., Durr J. & David G.. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains, Proc. Natl. Acad. Sci. USA., 94, 1997, 13683–13688.
Guo N.H.M., Krutzsch H.C., Negre E., Vogel T., Blake D.A. & Roberts D.D.. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion, Proc. Natl. Acad. Sci. USA, 89, 1992, 3040–3044a.
Guo N.H.M., Krutzsch H.C., Negre E., Zabrenetzky V.V. & Roberts D.D.. Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis, J. Biol. Chem, 267, 1992, 19349–19355b.
Herndon M.E., Stipp C.S. & Lander A.D.. Interactions of neural glycosaminoglycans and proteoglycans with protein ligandsassessment of selectivity, heterogeneity and the participation of core proteins in binding, Glycobiology, 9, 1999, 143–155.
Hogg N., MacDonald S., Slusarenko M. & Beverley P.C.. Monoclonal antibodies specific for human monocytes, granulocytes and endothelium, Immunology, 53, 1984, 753–767.[Medline]
Hynes R.O.. Cell adhesionold and new questions, Trends Cell Biol, 9, 1999, M33–M37.[Medline]
Jalkanen M., Nguyen H., Rapraeger A., Kurn N. & Bernfield M.. Heparan sulphate proteoglycans from mouse mammary epithelial cellslocalization on the cell surface with a monoclonal antibody, J. Cell Biol, 101, 1985, 976–984.
Kaesberg P.R., Ershler W.B., Esko J.D. & Mosher D.F.. Chinese hamster ovary cell adhesion to human platelet thrombospondin is dependent on cell surface heparan sulfate proteoglycan, J. Clin. Invest, 83, 1989, 994–1001.[Medline]
Kinashi T. & Springer T.A.. Adhesion molecules in hematopoietic cells, Blood Cells, 20, 1994, 25–44.[Medline]
Klass C.M., Couchman J.R. & Woods A.. Control of extracellular matrix assembly by syndecan-2 proteoglycan, J. Cell Sci., 113, 2000, 493–506.[Abstract]
Koda J.E., Rapraeger A. & Bernfield M.. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens, J. Biol. Chem, 260, 1985, 8157–8162.
Kokenyesi R. & Bernfield M.. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1, J. Biol. Chem, 269, 1994, 12304–12309.
Krutzsch H.C., Choe B.J., Sipes J.M., Guo N. & Roberts D.D.. Identification of an
3β1 integrin recognition site in thormbospondin-1, J. Biol. Chem, 274, 1999, 24080–24086.
Langford J.K., Stanley M.J., Cao D. & Sanderson R.D.. Multiple heparan sulfate chains are required for optimal syndecan-1 function, J. Biol. Chem, 273, 1998, 29965–29971.
Lawler J. & Hynes R.O.. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin, Blood, 74, 1989, 2022–2027.
Lawler J., Weinstein R. & Hynes R.O.. Cell attachment to thrombospondinthe role of ARG-GLY-ASP, calcium, and integrin receptors, J. Cell Biol, 107, 1988, 2351–2361.
Lebakken C.S. & Rapraeger A.C.. Syndecan-1 mediates cell spreading in transfected human lymphoblastiod (Raji) cells, J. Cell Biol, 132, 1996, 1209–1221.
Li W.X., Howard R.J. & Leung L.L.. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36, J. Biol. Chem, 268, 1993, 16179–16184.
Lindberg F.P., Bullard D.C., Caver T.E., Gresham H.D., Beaudet A.L. & Brown E.J.. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice, Science, 274, 1996, 795–798.
Liu W., Litwack E.D., Stanley M.J., Langford J.K., Lander A.D. & Sanderson R.D.. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions, J. Biol. Chem, 273, 1998, 22825–22832.
Longley R.L., Woods A., Fleetwood A., Cowling G.J., Gallagher J.T. & Couchman J.R.. Control of morphology, cytoskeleton and migration by syndecan-4, J. Cell Sci., 112, 1999, 3421–3431.[Abstract]
McFall A.J. & Rapraeger A.C.. Identification of an adhesion site within the syndecan-4 extracellular protein domain, J. Biol. Chem, 272, 1997, 12901–12904.
McFall A.J. & Rapraeger A.C.. Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4, J. Biol. Chem, 273, 1998, 28270–28276.
Mertens G., Cassiman J.J., Van den Berghe H., Vermylen J. & David G.. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties, J. Biol. Chem, 267, 1992, 20435–20443.
Miettinen H.M., Edwards S.N. & Jalkanen M.. Analysis of transport and targeting of syndecan-1effect of cytoplasmic tail deletions, Mol. Biol. Cell, 5, 1994, 1325–1339.[Abstract]
Mikhailenko I., Kounnas M.Z. & Strickland D.K.. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. A process facilitated by cell-surface proteoglycans, J. Biol. Chem, 270, 1995, 9543–9549.
Murphy-Ullrich J.E. & Hook M.. Thrombospondin modulates focal adhesions in endothelial cells, J. Cell Biol, 109, 1989, 1309–1319.
Oh E.-S., Couchman J.R. & Woods A.. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C, J. Biol. Chem, 272, 1997, 8133–8136a.
Oh E.-S., Couchman J.R. & Woods A.. Multimerisation of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C, J. Biol. Chem, 272, 1997, 11805–11811b.
Pancake S.J., Holt G.D., Mellouk S. & Hoffman S.L.. Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates, J. Cell Biol, 117, 1992, 1351–1357.
Rapraeger A., Jalkanen M. & Bernfield M.. Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells, J. Cell Biol, 103, 1986, 2683–2696.
Rapraeger A.C. & Ott V.L.. Molecular interactions of the syndecan core proteins, Curr. Opin. Cell Biol, 10, 1998, 620–628.[Medline]
Roberts D.D., Sherwood J.A. & Ginsburg V.. Platelet thrombospondin mediates attachment and spreading of human melanoma cells, J. Cell Biol, 104, 1987, 131–139.
Sanderson R.D., Sneed T.B., Young L.A., Sullivan G.L. & Lander A.D.. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan, J. Immunol., 148, 1992, 3902–3911.[Abstract]
Saoncella S., Echtermeyer F., Denhez F., Nowlen J.K., Mosher D.F., Robinson S.D., Hynes R.O. & Goetinck P.F.. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers, Proc. Natl. Acad. Sci. USA, 96, 1999, 2805–2810.
Saunders S.M., Jalkanen S., O'Farrell J. & Bernfield M.. Molecular cloning of syndecan, an integral membrane protein, J. Cell Biol, 108, 1989, 1547–1556.
Schwartz M.A., Schaller M.D. & Ginsberg M.H.. Integrinsemerging paradigms of signal transduction, Annu. Rev. Cell Dev. Biol, 11, 1995, 549–599.[Medline]
Sun X., Mosher D.F. & Rapraeger A.. Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin, J. Biol. Chem, 264, 1989, 2885–2889.
Sun X., Skorstengaard K. & Mosher D.F.. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin, J. Cell Biol, 118, 1992, 693–701.
Vuori K. & Ruoslahti E.. Activation of protein kinase C precedes
5β1 integrin-mediated cell spreading on fibronectin, J. Biol. Chem, 268, 1993, 21459–21462.
Wilson K.E., Li Z., Kara M., Gardner K.L. & Roberts D.D.. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides, J. Immunol, 163, 1999, 3621–3628.
Woods A., McCarthy J.B., Furcht L.T. & Couchman J.R.. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation, Mol. Biol. Cell, 6, 1993, 605–613.
Woods A. & Couchman J.R.. Syndecanssynergistic activators of cell adhesion, Trends Cell Biol, 8, 1998, 189–192.[Medline]
Woods A. & Couchman J.R.. Integrin modulation by lateral association, J. Biol. Chem, 275, 2000, 24233–24236.
Yabkowitz R., Dixit V.M. & Guo N.. Activated T-cell adhesion to thormbospondin is mediated by the VLA-4 and VLA-5 integrins, J. Immunol, 151, 1993, 149–158.[Abstract]
Yamada K.M. & Miyamoto S.. Integrin transmembrane signaling and cytoskeletal control, Curr. Opin. Cell Biol, 7, 1995, 681–689.[Medline]
Yamashiro-Matsumura S., Yamakita Y., Ono S. & Matsumura F.. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells, Mol. Biol. Cell., 9, 1998, 993–1006.
Zimmermann P. & David G.. The syndecans, tuners of transmembrane signaling, FASEB J, 13Suppl.1999, S91–S100.[Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|